All Products

Livagen 20 mg

Liver-Specific Peptide Bioregulator

Substance: Livagen (Liver Tissue Peptide Complex)
Strength: 20 mg/vial
Form: Lyophilized powder
Packaging: 2 mL sterile vial
Manufacturer: Dragon Pharma, Europe

Authentic Dragon Pharma Product

Free Shipping on Orders $800+

Discreet Packaging Guaranteed

$39.00 $65.00

Warehouse :

International

U.S. Domestic

You will save $26.00

Description
Specifications
Usage Guidelines
Storage
FAQ

Dragon Pharma Livagen

Livagen 20 mg represents a sophisticated approach to hepatic optimization through targeted peptide bioregulation. This liver-specific peptide complex, derived from carefully processed liver tissue extracts, operates at the epigenetic level to modulate gene expression, enhance detoxification capacity, and promote hepatocellular regeneration. Each vial contains 20 mg of pharmaceutical-grade Livagen peptide complex, manufactured in Dragon Pharma's EU-certified facilities using advanced extraction and purification techniques that preserve the bioactive peptide sequences essential for liver-specific epigenetic regulation and metabolic optimization.

Livagen functions as a tissue-specific bioregulator that targets hepatic gene expression through sophisticated epigenetic mechanisms. Unlike conventional liver support compounds that merely provide antioxidant protection or membrane stabilization, Livagen operates upstream by influencing transcription factors, chromatin remodeling complexes, and DNA methylation patterns that control liver-specific metabolic programming. This allows it to enhance expression of genes involved in phase I and II detoxification pathways, upregulate endogenous antioxidant systems (particularly glutathione synthesis and superoxide dismutase activity), optimize lipid and glucose metabolism within hepatocytes, and stimulate controlled hepatocyte proliferation and regeneration. For researchers investigating hepatoprotection during exposure to compounds like Anadrol Inj 50 or Superdrol 10, Livagen offers a model for studying epigenetic approaches to maintaining liver health under chemical stress.

The scientific mechanism involves organotropic peptide signaling—short, biologically active peptide sequences derived from liver tissue that retain their affinity for hepatic cells. These peptides interact with specific nuclear receptors and transcription factors in hepatocytes, modulating the expression of hundreds of genes involved in metabolic regulation, detoxification, cellular repair, and apoptosis control. This results in comprehensive hepatic optimization: improved synthesis and secretion of bile acids for enhanced fat digestion and toxin excretion, increased production of plasma proteins for optimal nutrient transport and hormone binding, optimized glucose homeostasis through improved insulin sensitivity in liver tissue, and strengthened cellular defense systems against oxidative and chemical stress. When compared to traditional hepatoprotective agents like silymarin or N-acetylcysteine, Livagen offers a more fundamental approach—it doesn't just defend the liver; it epigenetically reprograms it for optimal function and resilience.

Dragon Pharma's formulation utilizes a standardized peptide complex with consistent biological activity across production batches. The lyophilized powder ensures maximum stability for research applications, easily reconstituted with bacteriostatic water for subcutaneous administration. For investigators studying hepatic stress responses, metabolic disorders, or chemical hepatotoxicity, Livagen provides a sophisticated model for examining how epigenetic interventions might maintain metabolic efficiency, ensure proper nutrient processing, and prevent the cellular damage that can result from liver dysfunction. When studied alongside other tissue-specific peptides like Testagen 20 mg for testicular regeneration or Ovagen 20 mg for ovarian support, Livagen completes a picture of organ-specific peptide bioregulation with potential applications in systemic health optimization.

Key Research Applications:

Hepatocyte Regeneration Studies: Models controlled proliferation and differentiation of liver cells, providing insights into peptide-mediated tissue regeneration and recovery from chemical or metabolic injury in experimental systems.
Detoxification Pathway Optimization: Examines upregulation of cytochrome P450 enzymes for phase I detoxification and conjugating enzymes for phase II, offering models for enhanced metabolic clearance of xenobiotics and endogenous toxins.
Endogenous Antioxidant System Enhancement: Investigates peptide-mediated increases in glutathione synthesis, superoxide dismutase activity, and catalase production, providing models for comprehensive protection against oxidative stress in hepatic tissues.
Metabolic Function Regulation Research: Studies optimization of lipid metabolism pathways to prevent hepatic steatosis, enhancement of glucose regulation for metabolic stability, and improvement of protein synthesis for optimal hepatic function.
Epigenetic Modulation Mechanisms: Explores peptide influences on DNA methylation patterns, histone modifications, and transcription factor activity in liver cells, offering insights into epigenetic approaches to organ-specific health optimization.

Each 2 mL vial contains 20 mg of research-grade Livagen peptide complex, standardized for biological activity and manufactured under strict quality control standards in Dragon Pharma's certified European facilities for investigative use in approved research protocols.

Product Specifications

Product Name	Livagen 20 mg
Manufacturer	Dragon Pharma
Substance	Livagen (Liver Tissue Peptide Complex)
Packaging	2 mL sterile glass vial
Lab Test Result	Biologically standardized activity
Half-Life	Approximately 3-4 hours (epigenetic effects persist)
Recommended Cycle	4-8 weeks continuous research administration
Form	Lyophilized powder
Aromatization	None (non-hormonal peptide complex)
Research Dosage	100-300 mcg daily in animal models

Research Guidelines

Livagen is administered via subcutaneous injection in preclinical research models. Reconstitute the 20 mg vial with 1-2 mL of bacteriostatic water. For optimal liver targeting in research models, inject into abdominal subcutaneous tissue, which provides direct portal circulation delivery to the liver. Administer once daily, preferably in the morning to align with circadian rhythms of liver metabolism. Research doses typically range from 100-300 mcg daily, with effects being cumulative over weeks rather than immediate. For studies examining hepatoprotection during toxin exposure, begin administration 7-10 days before introducing hepatotoxic compounds to establish epigenetic preconditioning.

Hepatoprotection Studies (4 weeks): 100-150 mcg daily to investigate liver protection during exposure to compounds like Dianabol 50 or Anavar 50. Monitor liver enzymes, histological changes, and detoxification capacity markers throughout the study period.
Liver Regeneration Research (6 weeks): 200-250 mcg daily to examine hepatocyte proliferation and functional recovery after partial hepatectomy or chemical injury models. Often paired with BPC 157 research to compare peptide-mediated versus growth factor approaches to tissue repair.
Metabolic Optimization Investigations (8 weeks): 250-300 mcg daily to study effects on hepatic lipid metabolism, insulin sensitivity, and glucose regulation in metabolic disorder models. Can be examined alongside MOTS-C 10mg research to compare mitochondrial versus epigenetic approaches to metabolic health.

Experimental Design for Hepatotoxicity Studies:

When investigating protection against pharmaceutical hepatotoxicity: Pre-treat with Livagen for 10-14 days before introducing hepatotoxic compounds like Accutane or specific antibiotics. Monitor serum ALT, AST, ALP, GGT, total bilirubin, and albumin weekly. Terminal endpoints should include liver weight-to-body weight ratios, histological examination (H&E staining, Masson's trichrome for fibrosis), and assessment of lipid peroxidation markers (MDA, 4-HNE). Consider measuring cytochrome P450 activity and glutathione levels to assess detoxification capacity. When studying alongside TUDCA, compare mechanisms of membrane stabilization versus epigenetic regulation.

Combination Research Protocols:

Livagen combines effectively with other hepatic support approaches for comprehensive liver research.

With N-Acetylcysteine: Livagen provides epigenetic regulation while NAC supplies glutathione precursors for enhanced antioxidant defense.
With Milk Thistle extract: Compare traditional phytochemical protection versus peptide-mediated epigenetic optimization.
With Fish Oil: Study combined effects on hepatic lipid metabolism and inflammation control.

Research suggests complementary effects when epigenetic regulation is combined with nutrient support and membrane stabilization approaches.

Storage Instructions

Unreconstituted: Store lyophilized Livagen vials at 2-8°C (36-46°F) in their original packaging. The peptide complex maintains stability for 24 months under consistent refrigeration. Avoid freezing as ice crystal formation can damage the complex peptide structures. Protect from light exposure which can degrade bioactive sequences over time. Temperature fluctuations should be minimized to preserve peptide integrity.
Reconstituted: After mixing with bacteriostatic water, store immediately in refrigerator at 2-8°C (36-46°F). Use within 14 days for maximum potency in research applications. The solution remains stable at room temperature for up to 8 hours if needed for experimental procedures. Never freeze reconstituted peptide as this causes irreversible aggregation of peptide sequences and loss of biological activity.
Research Handling Notes: Use aseptic technique for all reconstitution and administration procedures. Gently swirl to dissolve powder—avoid vigorous shaking which can denature peptides. For accurate dosing in research models, draw into insulin syringes immediately after reconstitution if planning multiple administrations. Document storage conditions, reconstitution time, and administration details as critical variables in research methodology. Store away from strong electromagnetic fields which may theoretically affect peptide conformation.

What is Livagen peptide?

Livagen is a liver-specific peptide bioregulator derived from liver tissue extracts that modulates hepatic gene expression. It's designed to optimize liver function by regulating detoxification enzymes, enhancing antioxidant systems, promoting hepatocyte regeneration, and improving metabolic processes within liver cells through epigenetic mechanisms.

How long does it take for Livagen to work?

Initial improvements in liver enzyme markers (ALT, AST) may be observed within 10-14 days. Significant hepatoprotective effects and measurable liver function enhancement typically require 3-4 weeks of consistent use. Full epigenetic reprogramming and optimal liver regeneration benefits are achieved after 6-8 weeks of continuous administration in research models.

Can Livagen help with fatty liver?

Research suggests Livagen may support fatty liver resolution through multiple mechanisms: enhancing lipid metabolism within hepatocytes, improving insulin sensitivity in liver tissue, reducing hepatic inflammation, and promoting healthy liver cell regeneration. It appears to address both metabolic and inflammatory components of fatty liver disease in experimental models.

Is Livagen better than traditional liver supplements?

Livagen works through fundamentally different mechanisms than conventional liver supplements. While milk thistle and NAC provide antioxidant support, Livagen operates at the epigenetic level to regulate liver-specific gene expression. This allows it to not just protect existing liver cells but potentially reprogram liver function for long-term optimization and regeneration.

How should Livagen be administered for research purposes?

For preclinical research, Livagen is typically administered via subcutaneous injection at doses of 100-300 mcg daily. Reconstitute with bacteriostatic water, store refrigerated, and administer consistently for optimal epigenetic effects. Research suggests best results with continuous administration for 4-8 weeks, as effects are cumulative and depend on sustained gene expression modulation.

No customer reviews yet.